Alera Investment Advisors’s AstraZeneca AZN Stock Holding History

Alera Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$819K	Sell	5,259 -357	-6%	-$57.6K	0.1%	87
2024 Q2	$876K	Sell	5,616 -1,527	-21%	-$230K	0.11%	84
2024 Q1	$968K	Sell	7,143 -159	-2%	-$21.1K	0.13%	66
2023 Q4	$984K	Sell	7,302 -81	-1%	-$10.5K	0.13%	59
2023 Q3	$1,000K	Sell	7,383 -11	-0.1%	-$1.5K	0.16%	48
2023 Q2	$1.06M	Sell	7,394 -7	-0.1%	-$1.03K	0.23%	46
2023 Q1	$1.03M	Buy	7,401 +4,027	+119%	+$542K	0.24%	43
2022 Q4	$457K	Buy	3,374 +31	+0.9%	+$3.89K	0.11%	112
2022 Q3	$367K	Sell	3,343 -73	-2%	-$9.26K	0.1%	126
2022 Q2	$452K	Buy	3,416 +915	+37%	+$120K	0.13%	115
2022 Q1	$332K	Buy	+2,501	New	+$300K	0.08%	140
2019 Q2	–	Sell	-284	Closed	-$23K	–	159
2019 Q1	$23K	Sell	284 -114	-29%	-$8.99K	0.01%	259
2018 Q4	$30K	Buy	+398	New	+$31.1K	0.02%	226

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alera Investment Advisors's AZN Position: Q3 2024 in Review

Alera Investment Advisors reduced its AstraZeneca (AZN) stake by 6.4% in Q3 2024, selling an estimated $57.6K and leaving 5,259 shares worth $819K. The position accounts for 0.1% of the portfolio, ranked #87.

Alera Investment Advisors first reported a position in AZN in Q4 2018 and has held it in 13 quarters since. The position peaked at $1.06M in Q2 2023. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

Alera Investment Advisors held 5,259 shares of AstraZeneca worth $819K as of Q3 2024.
Alera Investment Advisors sold 357 AstraZeneca shares in Q3 2024, an estimated $57.6K.
AstraZeneca made up 0.1% of Alera Investment Advisors's portfolio in Q3 2024, its #87 holding.
Alera Investment Advisors first reported a position in AstraZeneca in Q4 2018 and has held it in 13 quarters since.
Alera Investment Advisors's AstraZeneca position peaked at $1.06M in Q2 2023.
1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on Alera Investment Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.